Trademark Details For AKROS (Serial Number 97156393)

  •  Home
  •  Print
AKROS
0
0
0
0
Serial Number  United States - USPTO 97156393
Registration Number -
Mark
AKROS
Filing Date Dec-04-2021
Status
Dead  
ABANDONED-FA.. (602)
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney Name
TTAB
0
Action Tags
  
  



  • Description Of Mark:
  • Color(s) Claimed:

009Electrical and scientific apparatus

U.S Class(es): 021, 023, 026, 036, 038

Class Status: Active

First Use: Jul-11-2021

First Use in Commerce: Jan-07-2022


24.15.04



Correspondences

NameAkros LLC
Address10707 LAKE CREEK PARKWAY #68 AUSTIN, TX 78750

Prosecution History

  
  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Dec-08-2021NEW APPLICATION ENTERED   NWAPI
Dec-08-2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Dec-09-2021NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Sep-13-2022ASSIGNED TO EXAMINER   DOCKD
Sep-14-2022EXAMINERS AMENDMENT -WRITTEN   CNEAR
Sep-14-2022EXAMINERS AMENDMENT E-MAILED   GNEAF
Sep-14-2022
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  
GNENO
Sep-14-2022ASSIGNED TO LIE   ALIEA
Sep-14-2022EXAMINER'S AMENDMENT ENTERED   XAECI
Sep-29-2022APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Oct-19-2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Nov-08-2022PUBLISHED FOR OPPOSITION   PUBOA
Nov-08-2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jan-03-2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Jan-05-2023TEAS STATEMENT OF USE RECEIVED   EISUI
Feb-06-2023CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Jan-05-2023USE AMENDMENT FILED   IUAFS
Sep-21-2023STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Oct-17-2023SU - NON-FINAL ACTION - WRITTEN   CNRTW
Oct-17-2023
NON-FINAL ACTION E-MAILED
  
GNRTO
Oct-17-2023
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Feb-21-2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE  
  
ABN2O
Feb-21-2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND  
  
MAB2E